202 related articles for article (PubMed ID: 17225279)
41. Delavirdine combination and viral load.
Anderson S
AIDS Treat News; 1997 Oct; (No 281):6. PubMed ID: 11364793
[TBL] [Abstract][Full Text] [Related]
42. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
[No Abstract] [Full Text] [Related]
43. Study shows people can safely switch to Atripla.
Proj Inf Perspect; 2008 Dec; (47):2. PubMed ID: 19226673
[No Abstract] [Full Text] [Related]
44. Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine.
Palacios R; Rivero A; Santos I; Ríos MJ; Castaño M; del Arco A; Santos González J;
HIV Clin Trials; 2010; 11(2):118-20. PubMed ID: 20542848
[No Abstract] [Full Text] [Related]
45. Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen.
Damond F; Matheron S; Peytavin G; Campa P; Taieb A; Collin G; Delaunay C; Chêne G; Brun-Vézinet F; Descamps D
Antivir Ther; 2004 Aug; 9(4):635-6. PubMed ID: 15456096
[No Abstract] [Full Text] [Related]
46. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
Gallant JE; Parish MA; Keruly JC; Moore RD
Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
[TBL] [Abstract][Full Text] [Related]
47. Emtricitabine: new preparation. An antiretroviral very similar to lamivudine.
Prescrire Int; 2005 Apr; 14(76):54-6. PubMed ID: 15875341
[TBL] [Abstract][Full Text] [Related]
48. FDA notifications. Two tenofovir containing products are approved.
AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795142
[No Abstract] [Full Text] [Related]
49. [One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful].
Warpakowski A
MMW Fortschr Med; 2009 Apr; 151(18):54-5. PubMed ID: 19769077
[No Abstract] [Full Text] [Related]
50. Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine.
Landman GW; Soonawala D
Clin Infect Dis; 2010 Apr; 50(8):1200; author reply 1200. PubMed ID: 20233045
[No Abstract] [Full Text] [Related]
51. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
52. 3TC approval may revive AZT's appeal.
Vazquez E
Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
[TBL] [Abstract][Full Text] [Related]
53. Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.
Bongiovanni M; Gianotti N; Chiesa E; Nasta P; Cicconi P; Capetti A; di Biagio A; Matti A; Tirelli V; Marconi P; de Luca A; Mussini C; Gatti F; Zaccarelli M; Abeli C; Torti C; Antinori A; Castagna A; d'Arminio Monforte A
Infection; 2007 Dec; 35(6):451-6. PubMed ID: 18034204
[TBL] [Abstract][Full Text] [Related]
54. Tenofovir and didanosine: a dangerous liaison.
Waters L; Maitland D; Moyle GJ
AIDS Read; 2005 Aug; 15(8):403-6, 413. PubMed ID: 16110555
[No Abstract] [Full Text] [Related]
55. Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.
Tamalet C; Tomei C; Henry M; Solas C; Villacian J; Colson P
AIDS; 2007 Nov; 21(18):2551-2. PubMed ID: 18025898
[No Abstract] [Full Text] [Related]
56. [Efficacy and safety of the substitution of zidovudine by nevirapine in treatments based on three nucleoside analogue reverse transcriptase inhibitors in HIV-1 infected patients].
Tasias M; Ruiz S; Deig E; Pedrol E
Enferm Infecc Microbiol Clin; 2011; 29(7):556-7. PubMed ID: 21565428
[No Abstract] [Full Text] [Related]
57. Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
Gutiérrez S; Guillemi S; Jahnke N; Montessori V; Harrigan PR; Montaner JS
Clin Infect Dis; 2008 Feb; 46(3):e28-30. PubMed ID: 18181733
[TBL] [Abstract][Full Text] [Related]
58. Clinical trials group: two studies are now open to patients who qualify.
Craig K
HIV Clin; 2000; 12(1):5. PubMed ID: 11810862
[No Abstract] [Full Text] [Related]
59. Anti-HIV agents. Continuing or stopping 3TC.
TreatmentUpdate; 2005; 17(5):7-8. PubMed ID: 17219658
[No Abstract] [Full Text] [Related]
60. [Complete HAART in a single pill. New milestone for improving compliance].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():40-1. PubMed ID: 19024916
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
